Nectar Lifescience Ltd Share Price

Q: What is the share price of Nectar Lifescience Ltd today?

Nectar Lifescience Ltd share price as on 12 Jun 2026 is ₹11.37

Pharmaceuticals

NSE: NECLIFE Small Cap ISIN: INE023H01027

As on 13 June 2026 at 01:06 IST

₹11.37

-0.02

(-0.18%)

Sell Buy

Over 1 Month

-16%

Over 6 Months

-45.61%

Over 1 Year

-53.09%

Over 3 Years

-35.28%

Nectar Lifescience Ltd Summary

Close ₹11.39

Open ₹11.50

High ₹11.50

Low ₹11.05

Volume 74,749

Net Turnover (in Cr) ₹0.084

52Wk High ₹25.50

52Wk Low ₹9.30

52Wk High / Low

9.30

25.50

Nectar Lifescience Ltd Fundamentals

Key Financial Data

Market Cap (in Cr) ₹221.26

EPS (TTM) -

Book Value (BV) 29.98

Div. Yield -

P/E (TTM) -0.75

Price/Book Value 0.38

Delivery % -

Face Value 1

Key Ratios

PE Ratio -

PB Ratio 0.54

EV to Sales 0.65

PEG Ratio -

ROA -7.35

ROE -11.23

Debt-Equity 0.60

Net Profit Margin -5.96

Operating Profit Margin -1.29

Nectar Lifescience Ltd Financials

Consolidated

Standalone

Yearly

Quarterly

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,674.96	1,698.66	1,566.85	1,680.15	1,547.09
Total Expenses	1,836.50	1,680.39	1,609.27	1,646.07	1,606.54
Profit Before Tax	-161.53	18.27	-42.42	34.08	-84.77
Profit After Tax	-113.68	5	-24.18	25.05	-73.26
Operating Profit After Depreciation	-86.96	105.41	37.07	112.89	52.58

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	633.11	642.71	661.97	723.10	771.89
Total Non Current Assets	809.64	907.23	958.03	1,035.98	1,232.29
Total Current Assets	1,237.59	1,283.83	1,231.18	1,354.85	1,238.83
Total Assets	2,047.22	2,191.06	2,189.21	2,390.83	2,471.12
Total Shareholder's Fund	956.11	1,069.25	1,064.60	1,087.90	1,062.03

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	169.44	224.69	133.65	95.01	21.38
Net Cash Used In Investing Activities	-41.93	-17.03	51.70	16.64	-28.62
Net Cash Used In Financing Activities	-128.09	-205.44	-185.58	-119.38	11.49

Profit and Loss

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Total Revenue	1,674.96	1,698.66	1,566.85	1,679.55	1,545.62
Total Expenses	1,836.50	1,680.39	1,607.54	1,645.20	1,604.95
Profit Before Tax	-161.53	18.28	-40.69	34.35	-84.65
Profit After Tax	-113.68	5	-22.46	25.32	-73.15
Operating Profit After Depreciation	-86.96	105.42	38.78	113.16	52.70

Balance Sheet

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Fixed Assets	633.11	642.71	661.97	723.10	771.89
Total Non Current Assets	809.65	907.23	958.04	1,035.95	1,149.25
Total Current Assets	1,237.58	1,283.83	1,231.17	1,353.75	1,237.57
Total Assets	2,047.23	2,191.06	2,189.21	2,389.71	2,386.82
Total Shareholder's Fund	956.11	1,069.25	1,064.60	1,086.86	1,060.73

Cash Flow

Particulars (in ₹ Cr.)	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Net Cash From Operating Activities	169.44	224.69	133.37	95.04	21.33
Net Cash Used In Investing Activities	-41.93	-17.03	52.03	16.64	-28.62
Net Cash Used In Financing Activities	-128.09	-205.44	-185.57	-119.38	11.49

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	1.29	-	0.71	5.24	0.01
Total Expenses	89.24	1.93	176.48	68.63	130.03
Profit Before Tax	-87.64	3.25	-175.85	-63.60	-130.14
Profit After Tax	-67.92	14.27	-176.01	-63.23	-130.09
Operating Profit after Depreciation	-81.66	33.53	-175.74	-63.07	-129.84

Particulars (in ₹ Cr.)	2026-03	2025-12	2025-09	2025-06	2025-03
Total Revenue	1.29	-	0.71	5.24	0.01
Total Expenses	89.23	1.93	176.39	68.63	130.03
Profit Before Tax	-87.63	3.25	-175.85	-63.60	-130.14
Profit After Tax	-67.92	14.27	-176.01	-63.23	-130.09
Operating Profit after Depreciation	-81.65	33.53	-175.65	-63.07	-129.84

Nectar Lifescience Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 11.13

S2 10.86

S3 10.68

Pivot 11.31

R1 11.58

R2 11.76

R3 12.03

Moving Average

20 SMA 12.13

50 SMA 11.97

100 SMA 12.39

200 SMA 14.35

Nectar Lifescience Ltd Corporate Actions

No available data

AGM Date: 21 Sep 2021

Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2021 and Outcome of Board Meeting as per attached letter Register of Members and Share Transfer Books will be closed from September 15, 2021 to September 21, 2021 (Both days inclusive) for the purpose of AGM. Accordingly the cut-off date, to ascertain the eligibility of members for remote e-voting and polling/ e-voting at AGM, is September 14, 2021 i.e. the date prior to the commencement of book closure. (AS Per BSE Announcement Dated on 23.07.2021) Pursuant to regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 please find enclosed herewith proceedings of Annual General Meeting held on September 21 2021. This is for your information and records please. Nectar Lifesciences Limited has submitted the Exchange a copy Scrutinizers report and outcome of Annual General Meeting held on September 21 2021. (Searchable Format) Nectar Lifesciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 (As Per BSE Announcement Dated on 9/21/2021 7:40:12 AM)

AGM Date: 21 Sep 2022

Register of Members and Share Transfer Books shall remain closed from September 15, 2022 to September 21, 2022 (Both days inclusive) for the purpose of AGM to be held on September 21, 2022. Accordingly, the cut-off date, to ascertain the eligibility of members for remote e-voting and polling/ e-voting at AGM, is September 14, 2022 i.e. the date prior to the commencement of book closure. To convene the 27th Annual General Meeting ('AGM') of the Members of the company on Wednesday, September 21, 2022. Board Meeting, inter-alia, has decided that: 1. 27th Annual General Meeting ('AGM') of the Members of the company to be held on Wednesday, September 21, 2022 and matters related thereto. Pursuant to Regulations 30 and 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copy of Annual Report for the financial year ended on March 31, 2022, containing therein inter alia, Notice of 27th Annual General Meeting to be held on September 21, 2022 at 11:00 AM. (As Per BSE Announcement Dated on 24.08.2022) Pursuant to regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith proceedings of 27th AGM held on September 21, 2022. (As Per BSE Announcement Dated on 21.09.2022) Nectar Lifesciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 22.09.2022)

AGM Date: 21 Sep 2023

AGM 21/09/2023 Outcome of Board Meeting - AGM and Book Closure (As Per BSE Announcement dated on 26.05.2023) Pursuant to Regulations 30 and 34 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith copy of Annual Report for the financial year ended on March 31, 2023, containing therein inter alia: 1. Notice of 28th Annual General Meeting ('AGM'). 2. Standalone Financial Statements, Directors and Auditors Report thereon. 3. Consolidated Financial Statements and Auditors Report thereon. 4. Corporate Governance Report. 5. Management Discussion and Analysis Report along with Attendance Slip and E-voting Instructions. The above details are also available on the website of the Company. (As Per BSE Announcement Dated on 11.08.2023) Please find attached herewith the outcome of Annual General meeting held on September 21, 2023 along with scrutinizer''s report Please find attached herewith the proceedings of AGM held on September 21, 2023. (As Per BSE Announcement dated on 21.09.2023)

AGM Date: 21 Sep 2024

AGM 21/09/2024 Please find herewith the proceedings of AGM held on September 21, 2024 (As per BSE Announcement Dated on 21/09/2024) Please find enclosed herewith copy of minutes of 29th AGM of the Company. (As Per BSE Announcement Dated on 28.09.2024)

AGM Date: 29 Sep 2025

AGM 29/09/2025 Please find attached notice of the 30th AGM for the financial year 2024-25 is scheduled to be held on Monday, September 29, 2025. This is in continuation of Company s letter no. NLL/CS/2025-545 dated August 26, 2025, vide which Notice of AGM has been informed to the exchanges. However, the page no. 3 has been missed out inadvertently in Notice of AGM. Please find attached revised notice of AGM. (As per BSE Announcement Dated on 26/08/2025) Please find herewith the proceedings of AGM held on Monday, September 29, 2025. (As Per Bse Announcement dated on 29/09/2025) Please find attached herewith copy of minutes of 30th AGM of the Company. (As per BSE Announcement dated on: 09.10.2025)

Nectar Lifescience Ltd Peer Comparison

Company	Price	Market Cap (in Cr)
Sun Pharmaceutical Industries Ltd	₹1,794.30	₹4,30,512.67
Divis Laboratories Ltd	₹6,651.25	₹1,76,569.79
Torrent Pharmaceuticals Ltd	₹4,570	₹1,54,669.57
Cipla Ltd	₹1,383	₹1,11,725.01
Zydus Lifesciences Ltd	₹1,105.65	₹1,11,254.26

Nectar Lifescience Ltd Top Mutal Funds Invested

Fund Name	AUM
Bandhan BSE Healthcare Index Fund	0.01%

Nectar Lifescience Ltd News

Nectar Lifescience to discuss results

On 30 May 2026

26 May 2026, 03:48 pm

Nectar Lifescience announces board meeting date

On 23 January 2026

19 Jan 2026, 05:41 pm

Nectar Lifescience to conduct board meeting

On 3 December 2025

28 Nov 2025, 10:28 am

Nectar Lifescience announces board meeting date

On 14 November 2025

10 Nov 2025, 10:41 am

Nectar Lifescience to convene AGM

On 29 September 2025

28 Aug 2025, 01:45 pm

Nectar Lifescience Ltd Stock Analysis

Annual revenue for Nectar Lifescience Ltd decreased by 1.40% to ₹1,674.96 crore in FY 2025 from ₹1,698.66 crore in FY 2024.
Annual Net Profit for Nectar Lifescience Ltd decreased by 2372.71% to ₹-113.68 crore in FY 2025 from ₹5 crore in FY 2024.
Promoter Shareholding in Nectar Lifescience Ltd remains unchanged by 0.00% in the most recent quarter, from 51.84% in January 2026 to 51.84% in March 2026.
Nectar Lifescience Ltd delivered a 1-year return of -53.09% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
Nectar Lifescience Ltd share price moved down by 0.18% from its previous close of INR ₹11.39. The latest Nectar Lifescience Ltd share price is INR ₹11.37.
Nectar Lifescience Ltd share price today has been at a low of 11.05 and a high of 11.40. Over the past 52 weeks, the Nectar Lifescience Ltd share price has seen a low of 9.30 and a high of 25.50.